BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2025 9:26:55 AM | Browse: 202 | Download: 1202
Publication Name World Journal of Diabetes
Manuscript ID 101328
Country China
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry & Molecular Biology
Manuscript Type Basic Study
Article Title SMAD specific E3 ubiquitin protein ligase 1 accelerates diabetic macular edema progression by WNT inhibitory factor 1
Manuscript Source Unsolicited Manuscript
All Author List Li-Fang Liang, Jia-Qi Zhao, Yi-Fei Wu, Hui-Jie Chen, Tian Huang and Xiao-He Lu
ORCID
Author(s) ORCID Number
Xiao-He Lu http://orcid.org/0000-0003-2173-7290
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Guangdong Province of China 2022A1515012346
Corresponding Author Xiao-He Lu, Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, No. 253 Gongye Avenue Central, Guangzhou 515282, Guangdong Province, China. luxh63@163.com
Key Words Diabetic macular edema; Retinal pigment epithelium cells; Autophagy; SMAD specific E3 ubiquitin protein ligase 1; WNT inhibitory factor 1; N6-methyladenosine modification; Vascular endothelial growth factor signaling pathway
Core Tip In this study, we demonstrated that insulin like growth factor 2 mRNA binding protein 2 upregulates SMAD-specific E3 ubiquitin protein ligase (SMURF) 1 expression in an N6-methyladenosine-dependent manner, and subsequently SMURF1 activates the Wnt/β-catenin-vascular endothelial growth factor signaling pathway by promoting ubiquitination and degradation of WNT inhibitory factor 1 to promote autophagy, which ultimately disrupts the tight junctions of the retinal pigment epithelium cells and thus led to diabetic macular edema.
Publish Date 2025-01-21 09:26
Citation

Liang LF, Zhao JQ, Wu YF, Chen HJ, Huang T, Lu XH. SMAD specific E3 ubiquitin protein ligase 1 accelerates diabetic macular edema progression by WNT inhibitory factor 1. World J Diabetes 2025; 16(3): 101328

URL https://www.wjgnet.com/1948-9358/full/v16/i3/101328.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i3.101328
Full Article (PDF) WJD-16-101328-with-cover.pdf